tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Scorpion Stings D065008 1 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Retrognathia D063173 1 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Candidiasis, Invasive D058365 2 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Leukoencephalopathies D056784 3 associated lipids
Netherton Syndrome D056770 1 associated lipids
Latent Tuberculosis D055985 1 associated lipids
Invasive Pulmonary Aspergillosis D055744 1 associated lipids
Keratosis, Actinic D055623 3 associated lipids
Multiple Pulmonary Nodules D055613 2 associated lipids
Pancreatitis, Graft D055589 1 associated lipids
Failed Back Surgery Syndrome D055111 3 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Posterior Leukoencephalopathy Syndrome D054038 1 associated lipids
Dysuria D053159 1 associated lipids
Nocturia D053158 1 associated lipids
Delayed Graft Function D051799 2 associated lipids
Renal Insufficiency D051437 8 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Granulomatosis, Orofacial D051261 2 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Diabetes Complications D048909 4 associated lipids
Hepatic Insufficiency D048550 1 associated lipids
Colitis, Collagenous D046729 1 associated lipids
Protoporphyria, Erythropoietic D046351 1 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Ileus D045823 3 associated lipids
Intestinal Volvulus D045822 1 associated lipids
Cholecystolithiasis D041761 2 associated lipids
Mastocytosis, Cutaneous D034701 1 associated lipids
Hypoalbuminemia D034141 1 associated lipids
Hyperuricemia D033461 4 associated lipids
Papillomavirus Infections D030361 4 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Polyomavirus Infections D027601 1 associated lipids
Coronary Stenosis D023921 6 associated lipids
Lacerations D022125 1 associated lipids
Brachial Plexus Neuritis D020968 2 associated lipids
Neuroaspergillosis D020953 2 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Central Nervous System Viral Diseases D020805 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Ishida A et al. Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis. 1998 Transfusion pmid:9738624
Reitamo S et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. 1998 J. Invest. Dermatol. pmid:9740230
Walensky LD et al. The 12 kD FK 506 binding protein FKBP12 is released in the male reproductive tract and stimulates sperm motility. 1998 Mol. Med. pmid:9742506
Brooksbank RL et al. Treatment of normal skeletal muscle with FK506 or rapamycin results in halothane-induced muscle contracture. 1998 Anesthesiology pmid:9743407
Quijano Y et al. Tolerance: a study in long-term surviving animals after small bowel transplantation. 1998 Transplant. Proc. pmid:9745494
Alessiani M et al. Effect of perioperative donor bone marrow infusion after small bowel transplantation in swine: preliminary results. 1998 Transplant. Proc. pmid:9745496
Chen H et al. Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse. 1998 Transplant. Proc. pmid:9745497
Walgenbach KJ et al. Upregulation of basic fibroblast growth factor during chronic rejection of rat intestinal allografts and its downregulation by FK 506. 1998 Transplant. Proc. pmid:9745501
Gatti S et al. Graft-versus-host reaction and graft rejection after liver, small bowel or small bowel allotransplantation in the pig. 1998 Transplant. Proc. pmid:9745509
Gasser M et al. Effect of selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 MAb in rat small bowel transplantation. 1998 Transplant. Proc. pmid:9745510
Dutta S et al. Liposomal tacrolimus and intestinal drug concentration. 1998 Transplant. Proc. pmid:9745533
Timmermann W et al. Noninvasive videomicroscopic monitoring of rat small bowel rejection. 1998 Transplant. Proc. pmid:9745537
Greenstein SM et al. Nifedipine prevents tacrolimus-induced intestinal hemodynamic and functional impairments. 1998 Transplant. Proc. pmid:9745540
Maroun T et al. Rejection therapy with tacrolimus in renal transplantation: preliminary results of a collaborative multicenter study in 45 patients. Groupe Cooperatif de Transplantation D'ile de France (GCIF). 1998 Transplant. Proc. pmid:9745576
Antoine C et al. Vascular microthrombosis in renal transplant recipients treated with tacrolimus. 1998 Transplant. Proc. pmid:9745577
Fornairon S et al. Can we improve the results of simultaneous pancreas-kidney transplantation? 1998 Transplant. Proc. pmid:9745580
Ratanatharathorn V et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. 1998 Blood pmid:9746768
Weinbrenner C et al. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. 1998 Cardiovasc. Res. pmid:9747435
Armenti VT et al. Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. 1998 Drug Saf pmid:9747668
Sakaguchi M et al. Cytokine production by T cells infiltrating in the eye of uveitis patients. 1998 Jul-Aug Jpn. J. Ophthalmol. pmid:9749865
Paterson DL et al. Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil. 1998 Transplantation pmid:9753337
Woodle ES et al. Liver transplantation in the first three months of life. 1998 Transplantation pmid:9753340
Radkowski M et al. Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. 1998 Transplantation pmid:9753352
Xu Q et al. Molecular characterization of a plant FKBP12 that does not mediate action of FK506 and rapamycin. 1998 Plant J. pmid:9753776
Teshima R et al. Ca2+-ATPase inhibitors and PKC activation synergistically stimulate TNF-alpha production in RBL-2H3 cells. 1998 Inflamm. Res. pmid:9754866
Ishizuka T et al. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells. 1998 J. Immunol. pmid:9759885
Schambeck CM et al. Limit of quantification (functional sensitivity) of the new IMx Tacrolimus II microparticle enzyme immunoassay. 1998 Clin. Chem. pmid:9761266
Kliem V and Brunkhorst R Tacrolimus in kidney transplantation. 1998 Contrib Nephrol pmid:9761977
Ohye H et al. Cellular signaling mechanisms for stimulation of growth hormone secretion and growth hormone primary transcripts by immunosuppressant agents, FK506 and cyclosporin A, in cultured rat pituitary cells. 1998 Nov-Dec Neuroimmunomodulation pmid:9762012
Zonneveld IM et al. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. 1998 Arch Dermatol pmid:9762021
Karanam BV et al. Disposition of L-732,531, a potent immunosuppressant, in rats and baboons. 1998 Drug Metab. Dispos. pmid:9763399
Billaud EM et al. Evidence for a pharmacokinetic interaction between itraconazole and tacrolimus in organ transplant patients. 1998 Br J Clin Pharmacol pmid:9764970
Wang JD et al. Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection. 1998 Immunology pmid:9767457
Hauser IA et al. Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells. 1998 Kidney Int. pmid:9767529
Lamb ML and Jorgensen WL Investigations of neurotrophic inhibitors of FK506 binding protein via Monte Carlo simulations. 1998 J. Med. Chem. pmid:9767630
Bennett WM The nephrotoxicity of new and old immunosuppressive drugs. 1998 Ren Fail pmid:9768435
Luo Z et al. Calcineurin inhibitors and cardiac hypertrophy. 1998 Nat. Med. pmid:9771723
Gómez J et al. The Bcl-2 gene is differentially regulated by IL-2 and IL-4: role of the transcription factor NF-AT. 1998 Oncogene pmid:9771966
Fellermann K et al. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). 1998 Am. J. Gastroenterol. pmid:9772045
Chelmicka-Schorr E et al. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats. 1998 J. Autoimmun. pmid:9776710
Weichert G and Sauder DN Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum. 1998 J. Am. Acad. Dermatol. pmid:9777778
Motamedi H and Shafiee A The biosynthetic gene cluster for the macrolactone ring of the immunosuppressant FK506. 1998 Eur. J. Biochem. pmid:9780228
Maestri M et al. [Treatment of the nephrotoxicity of immunosuppressive drugs with insulin-like growth factor-I]. 1998 Minerva Chir pmid:9780630
Nishida T et al. [FK506 for the prophylaxis of graft-versus-host-disease after bone marrow transplantation from HLA-genotypically mismatched unrelated donor]. 1998 Rinsho Ketsueki pmid:9785975
Rayes N et al. Pregnancies following liver transplantation--how safe are they? A report of 19 cases under cyclosporine A and tacrolimus. 1998 Clin Transplant pmid:9787947
Peddi VR et al. Use of tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation. 1998 Clin Transplant pmid:9787948
Wu A et al. Outcome of 22 successful pregnancies after liver transplantation. 1998 Clin Transplant pmid:9787957
Heering P et al. Distal tubular acidosis induced by FK506. 1998 Clin Transplant pmid:9787958
Masugi T and Otsuka K [Immunosuppressive drugs and calcineurin]. 1998 Tanpakushitsu Kakusan Koso pmid:9788176
Bajaj-Elliott M et al. Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. 1998 J. Clin. Invest. pmid:9788959